64
Participants
Start Date
November 30, 2011
Primary Completion Date
January 31, 2013
Study Completion Date
May 31, 2013
Neopuff
"* Group I neonates (Experimental group) includes 30 newborns showing signs of TTN who will receive administration of CPAP (5 cm of H2O) via T- piece (Neopuff; Fisher and Paykel Healthcare, Auckland, New Zealand).~* Group II neonates (Control group) includes 30 newborns who will receive nasal prong oxygen treatment; standard care according to Siva Subramanian et al. (2010)."
Ain Shams University
OTHER